Publications by authors named "Michael E Thase"

92Publications

Quality of life after response to acute-phase cognitive therapy for recurrent depression.

J Affect Disord 2020 Sep 15;278:218-225. Epub 2020 Sep 15.

Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9149, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2020.09.059DOI Listing
September 2020

Quality of life after response to acute-phase cognitive therapy for recurrent depression.

J Affect Disord 2020 Sep 15;278:218-225. Epub 2020 Sep 15.

Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9149, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2020.09.059DOI Listing
September 2020

Charting Sea Changes in Outpatient Pharmacotherapy of Bipolar Disorder.

Authors:
Michael E Thase

Am J Psychiatry 2020 Aug;177(8):651-653

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, and Corporal Michael J. Crescenz VA Medical Center, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2020.20060849DOI Listing
August 2020

Do patients' cognitive therapy skills predict personality change during treatment of depression?

Behav Res Ther 2020 Jul 20;133:103695. Epub 2020 Jul 20.

Department of Psychiatry, The University of Texas Southwestern Medical Center, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brat.2020.103695DOI Listing
July 2020

Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression.

Am J Geriatr Psychiatry 2020 Sep 19;28(9):933-945. Epub 2020 May 19.

University of Michigan Comprehensive Depression Center and Department of Psychiatry (SVP, JFG), National Network of Depression Centers, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2020.05.005DOI Listing
September 2020

Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysis.

Depress Anxiety 2020 May 17;37(5):485-495. Epub 2020 Apr 17.

Medical Department, ACADIA Pharmaceuticals Inc., San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/da.23017DOI Listing
May 2020

Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysis.

Depress Anxiety 2020 May 17;37(5):485-495. Epub 2020 Apr 17.

Medical Department, ACADIA Pharmaceuticals Inc., San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/da.23017DOI Listing
May 2020

Response to the letter entitled "Tachyphylaxis and Desensitization Depression" by Richard Skaff.

Authors:
Michael E Thase

CNS Spectr 2019 Nov 21:1-2. Epub 2019 Nov 21.

Department of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S109285291900169XDOI Listing
November 2019

Response to the letter entitled "Tachyphylaxis and Desensitization Depression" by Richard Skaff.

Authors:
Michael E Thase

CNS Spectr 2019 Nov 21:1-2. Epub 2019 Nov 21.

Department of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S109285291900169XDOI Listing
November 2019

Is sleep disturbance linked to short- and long-term outcomes following treatments for recurrent depression?

J Affect Disord 2020 Feb 31;262:323-332. Epub 2019 Oct 31.

Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2019.10.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919563PMC
February 2020

Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial.

J Clin Psychiatry 2019 10 31;80(6). Epub 2019 Oct 31.

University of Michigan Comprehensive Depression Center and Department of Psychiatry, and National Network of Depression Centers, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.19m12910DOI Listing
October 2019

Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies.

Expert Opin Pharmacother 2019 Oct 10;20(15):1907-1916. Epub 2019 Jul 10.

Otsuka Pharmaceutical Development & Commercialization Inc ., Princeton , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2019.1638913DOI Listing
October 2019

Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?

Behav Ther 2019 07 8;50(4):765-777. Epub 2018 Dec 8.

The University of Texas Southwestern Medical Center. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beth.2018.11.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582988PMC
July 2019

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.

Am J Psychiatry 2019 06 21;176(6):428-438. Epub 2019 May 21.

Janssen Research and Development, Beerse, Belgium (Popova); Janssen Research and Development, Titusville, N.J. (Daly, Lane, Lim, Hough, Manji, Drevets); the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Trivedi); Janssen Research and Development, Spring House, Pa. (Cooper); Janssen Canada, Toronto (Mazzucco); the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Thase); the Department of Psychiatry, University of Alabama School of Medicine, Birmingham (Shelton); Clínica Universidad de Navarra, Pamplona, Spain (Molero); Institute of Neuroscience, University of Barcelona, Hospital Clinic, IDIBAPS, CIBERSAM, Barcelona, Spain (Vieta); Charité Universitätsmedizin Berlin, Berlin (Bajbouj); Janssen Research and Development, San Diego (Singh).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2019.19020172DOI Listing
June 2019

Estimating outcome probabilities from early symptom changes in cognitive therapy for recurrent depression.

J Consult Clin Psychol 2019 Jun 22;87(6):510-520. Epub 2019 Apr 22.

Department of Psychiatry, The University of Texas Southwestern Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1037/ccp0000409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853186PMC
June 2019

The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF).

J Psychiatr Res 2019 06 22;113:125-136. Epub 2019 Mar 22.

Duke-NUS Medical School, Singapore; Duke University, Durham, NC, USA; Texas Tech University, Permian Basin, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2019.03.021DOI Listing
June 2019

Computer-Assisted Cognitive-Behavior Therapy for Depression: A Systematic Review and Meta-Analysis.

J Clin Psychiatry 2019 03 19;80(2). Epub 2019 Mar 19.

Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.18r12188DOI Listing
March 2019

Current and Emerging Treatments to Address Unmet Needs in MDD.

Authors:
Michael E Thase

J Clin Psychiatry 2019 Jan/Feb;80(1)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.AL18009BR1CDOI Listing
November 2019

Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.

Psychopharmacol Bull 2018 06;48(4):62-80

Earley, MD, Associate Vice President, Clinical Development, Allergan, plc., Madison, New Jersey, USA. Guo, PhD, Director, Biostatistics, Allergan, plc., Madison, New Jersey, USA. Németh, MD, Chief Medical Officer, Medical Division, Gedeon Richter Plc, Budapest, Hungary. Harsányi, MD, Clinical Project Manager, Clinical Development Unit of Central Nervous System, Gedeon Richter Plc, Budapest, Hungary. Thase, MD, Professor of Psychiatry, Director, Mood and Anxiety Program, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294423PMC
June 2018

Partner criticism during acute-phase cognitive therapy for recurrent major depressive disorder.

Behav Res Ther 2019 02 21;113:48-56. Epub 2018 Dec 21.

Department of Psychiatry, The University of Texas Southwestern Medical Center, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brat.2018.12.010DOI Listing
February 2019

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies.

Neuropsychiatr Dis Treat 2019 20;15:37-45. Epub 2018 Dec 20.

Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
https://www.dovepress.com/adjunctive-brexpiprazole-in-patien
Publisher Site
http://dx.doi.org/10.2147/NDT.S185815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305164PMC
December 2018

Improving Depression Outcome by Patient-Centered Medical Management.

Am J Psychiatry 2018 12 17;175(12):1187-1198. Epub 2018 Sep 17.

From the Duke-National University of Singapore Graduate Medical School, Singapore; the Department of Psychiatry, Duke University Medical School, Durham, N.C.; the Department of Psychiatry, Texas Tech Health Sciences Center-Permian Basin, Midland-Odessa; the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia; and the Corporal Michael J. Crescenz VA Medical Center, Philadelphia.

View Article

Download full-text PDF

Source
http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2018.18
Publisher Site
http://dx.doi.org/10.1176/appi.ajp.2018.18040398DOI Listing
December 2018

Preliminary support for the role of reward relevant effort and chronotype in the depression/insomnia comorbidity.

J Affect Disord 2019 01 15;242:220-223. Epub 2018 Aug 15.

Cpl. Michael J. Crescenz VA Medical Center, Philadelphia, PA, United States; Department of Psychiatry, The Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2018.08.057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172954PMC
January 2019

Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?

J Affect Disord 2019 01 25;242:150-158. Epub 2018 Aug 25.

Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2018.08.053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151272PMC
January 2019

Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial.

Int Clin Psychopharmacol 2018 11;33(6):304-311

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166708PMC
November 2018

Computer-Assisted Cognitive-Behavior Therapy for Depression in Primary Care: Systematic Review and Meta-Analysis.

Prim Care Companion CNS Disord 2018 Mar 1;20(2). Epub 2018 Mar 1.

Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/PCC.17r02196DOI Listing
March 2018

A Note From the ASCP President.

Authors:
Michael E Thase

J Clin Psychiatry 2018 Jan/Feb;79(1)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.17ac12081DOI Listing
March 2018

New medications for treatment-resistant depression: a brief review of recent developments.

Authors:
Michael E Thase

CNS Spectr 2017 12;22(S1):39-48

Department of Psychiatry,Perelman School of Medicine of the University of Pennsylvania,Corporal Michael J. Crescenz Veterans Affairs Medical Center,Philadelphia,Pennsylvania,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1092852917000876DOI Listing
December 2017

Patients' comprehension and skill usage as a putative mediator of change or an engaged target in cognitive therapy: Preliminary findings.

J Affect Disord 2018 01 27;226:163-168. Epub 2017 Sep 27.

Departments of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, Philadelphia Veterans Affairs Medical Center, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2017.09.045DOI Listing
January 2018

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.

World J Biol Psychiatry 2018 08 6;19(5):330-348. Epub 2017 Oct 6.

a School of Medicine, Barwon Health , Deakin University, IMPACT SRC (Innovation in Mental and Physical Health and Clinical Treatment - Strategic Research Centre) , Geelong , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15622975.2017.1379609DOI Listing
August 2018

Improving the Efficiency of Psychotherapy for Depression: Computer-Assisted Versus Standard CBT.

Am J Psychiatry 2018 03 3;175(3):242-250. Epub 2017 Oct 3.

From the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia; the Department of Psychiatry and Behavioral Sciences, University of Louisville, Louisville; the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh; and King's Health Economics, Institute of Psychiatry, Psychology, and Neuroscience, King's College London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2017.17010089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848497PMC
March 2018

Meta-Analysis of the Antidepressant Effects of Acute Sleep Deprivation.

J Clin Psychiatry 2017 Sep/Oct;78(8):e1020-e1034

Department of Psychiatry, University of Pennsylvania, 3535 Market St, Ste 670, Philadelphia, PA 19104.

View Article

Download full-text PDF

Source
http://www.psychiatrist.com/JCP/article/Pages/2017/v78n08/16
Publisher Site
http://dx.doi.org/10.4088/JCP.16r11332DOI Listing
November 2017

Relations of Shared and Unique Components of Personality and Psychosocial Functioning to Depressive Symptoms.

J Pers Disord 2018 10 13;32(5):577-602. Epub 2017 Sep 13.

Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1521/pedi_2017_31_313DOI Listing
October 2018

Gauging the Use of Second-Generation Antipsychotics: Medicaid Benefits Data Suggest Much Room for Improvement.

Authors:
Michael E Thase

J Clin Psychiatry 2018 Mar/Apr;79(2)

University of Pennsylvania School of Medicine, Mood and Anxiety Disorders Treatment and Research Program, Department of Psychiatry, 3535 Market St, Ste 670, Philadelphia, PA 19104.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.17com11460DOI Listing
June 2019

Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder.

Eur Neuropsychopharmacol 2017 08 27;27(8):773-781. Epub 2017 Jun 27.

Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0924977X173025
Publisher Site
http://dx.doi.org/10.1016/j.euroneuro.2017.05.009DOI Listing
August 2017

Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg/day versus placebo in the PREVENT study.

Int Clin Psychopharmacol 2017 09;32(5):271-280

aKyorin University School of Medicine bPfizer Japan Inc, Tokyo, Japan cPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania dPfizer Inc, New York City, New York ePfizer Inc, La Jolla, California fVirginia Commonwealth University, Richmond, Virginia, USA gPfizer Canada Inc, Kirkland, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000183DOI Listing
September 2017

Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg/day versus placebo in the PREVENT study.

Int Clin Psychopharmacol 2017 09;32(5):271-280

aKyorin University School of Medicine bPfizer Japan Inc, Tokyo, Japan cPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania dPfizer Inc, New York City, New York ePfizer Inc, La Jolla, California fVirginia Commonwealth University, Richmond, Virginia, USA gPfizer Canada Inc, Kirkland, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000183DOI Listing
September 2017

Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg/day versus placebo in the PREVENT study.

Int Clin Psychopharmacol 2017 09;32(5):271-280

aKyorin University School of Medicine bPfizer Japan Inc, Tokyo, Japan cPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania dPfizer Inc, New York City, New York ePfizer Inc, La Jolla, California fVirginia Commonwealth University, Richmond, Virginia, USA gPfizer Canada Inc, Kirkland, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000183DOI Listing
September 2017

Data-Driven Subgroups in Depression Derived from Directed Functional Connectivity Paths at Rest.

Neuropsychopharmacology 2017 Dec 12;42(13):2623-2632. Epub 2017 May 12.

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npp.2017.97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686504PMC
December 2017

Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.

Psychiatry Res 2017 07 22;253:174-181. Epub 2017 Mar 22.

Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2017.03.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481171PMC
July 2017

Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study.

CNS Spectr 2017 Apr 30;22(2):236-245. Epub 2017 Mar 30.

1Sunovion Pharmaceuticals Inc.,Fort Lee,New Jersey,and Marlborough,Massachusetts,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1092852917000074DOI Listing
April 2017

Managing Medical Comorbidities in Patients With Depression to Improve Overall Prognosis.

Authors:
Michael E Thase

J Clin Psychiatry 2016 Nov;77(11):e1496

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.14077cc5cDOI Listing
November 2016

Anhedonia in the daily lives of depressed Veterans: A pilot report on experiential avoidance as a moderator of emotional reactivity.

J Affect Disord 2017 Jan 21;208:414-417. Epub 2016 Oct 21.

The Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, USA; Perelman School of Medicine of the University of Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2016.10.011DOI Listing
January 2017

Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial.

J Clin Psychiatry 2016 Oct;77(10):e1316-e1323

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, and the Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.15m10244DOI Listing
October 2016

Ketamine: stimulating antidepressant treatment?

BJPsych Open 2016 May 11;2(3):e5-e9. Epub 2016 May 11.

, MD, Professor and Chairman of the Department of Psychiatry & Behavioural Sciences at the University of New Mexico, Albuquerque, NM, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjpo.bp.116.002923DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995167PMC
May 2016

The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.

Am J Psychiatry 2017 04 3;174(4):341-348. Epub 2016 Oct 3.

From the Department of Medical Epidemiology and Biostatistics and the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; the Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York; the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Department of Psychological and Brain Sciences, Indiana University, Bloomington; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm; the Department of Medical Sciences, Örebro University, Örebro, Sweden; and the Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2016.16040467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641557PMC
April 2017

Defined symptom-change trajectories during acute-phase cognitive therapy for depression predict better longitudinal outcomes.

Behav Res Ther 2016 12 18;87:48-57. Epub 2016 Aug 18.

Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9149, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brat.2016.08.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127736PMC
December 2016

Adverse Effects of Second-Generation Antipsychotics as Adjuncts to Antidepressants: Are the Risks Worth the Benefits?

Authors:
Michael E Thase

Psychiatr Clin North Am 2016 09 17;39(3):477-86. Epub 2016 Jun 17.

Mood and Anxiety Treatment and Research Program, Perelman School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 670, Philadelphia, PA 19104-3309, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psc.2016.04.008DOI Listing
September 2016

Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder.

Int Clin Psychopharmacol 2016 11;31(6):332-40

aDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania bAllergan, Inc., Jersey City, New Jersey cInstitute for Advanced Medical Research, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049949PMC
November 2016

Practising evidence-based medicine in an era of high placebo response: number needed to treat reconsidered.

Br J Psychiatry 2016 05;208(5):416-20

Steven P. Roose, MD, Bret R. Rutherford, MD, Melanie M. Wall, PhD, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, USA; Michael E. Thase, Departments of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, Philadelphia Veterans Affairs Medical Center and University of Pittsburgh Medical Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.bp.115.163261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853640PMC
May 2016

A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults.

Eur Neuropsychopharmacol 2016 06 25;26(6):979-93. Epub 2016 Mar 25.

Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euroneuro.2016.03.007DOI Listing
June 2016

Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.

J Affect Disord 2016 Jul 13;199:148-56. Epub 2016 Apr 13.

Department of Psychiatry, The University of Texas Southwestern Medical Center, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2016.04.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862892PMC
July 2016

Adjunctive Therapy With Second-Generation Antipsychotics: The New Standard for Treatment-Resistant Depression?

Authors:
Michael E Thase

Focus (Am Psychiatr Publ) 2016 Apr 7;14(2):180-183. Epub 2016 Apr 7.

Dr. Thase is with the Perelman School of Medicine, University of Pennsylvania, and Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (e-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.focus.20150041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519649PMC
April 2016

Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.

Am J Psychiatry 2016 May 12;173(5):499-508. Epub 2016 Feb 12.

From the Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston; Alkermes, Inc., Waltham, Mass.; the Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia; McLean Hospital, Belmont, Mass.; and the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2015.15070921DOI Listing
May 2016